.png){kind=icon}
返回
PSA DECREASE DURING COMBINED-MODALITY RADIOTHERAPY PREDICTS FOR TREATMENT OUTCOME
.png){kind=icon}
PRE
AI
DOI：10.1016/j.ijrobp.2009.08.064.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Purpose: Prostate-specific antigen (PSA) is the well-used marker in the diagnosis, prognosis, and follow-up for prostate cancer patients. Although reports have focused on the importance of pretreatment PSA levels, doubling time, and posttreatment nadirs, there is little information on the value of PSA during the course of radiotherapy. Methods and Materials: Retrospective review of PSA values obtained midway through a course of radiotherapy treatment for prostate cancer. Patients had a PSA (midPSA) measured after a course of external beam radiation (EBRT) before planned transperineal low-dose-rate brachytherapy implant (LDR). Results: A total of 717 patients were analyzed with a median follow-up of 5.8 years, all censored patients had a minimum follow-up of 2 years. A total of 277 patients had low-risk disease, 267 patients had intermediate risk, and 173 patients had high-risk disease. Androgen blockade was used in 512 patients. A total of 653 patients had a midPSA decrease after EBRT, the median decrease was 6.2 ng/mL. Patients who had a midPSA decrease >= 25% compared with pretreatment PSA had improved overall survival of 10.0 vs. 7.4 years (p < 0.0004) and improved disease-free survival of 9.8 vs. 7.3 years (p < 0.01). When stratified by use of androgen blockade, midPSA remained significant for both androgen and non-androgen patients. Conclusions: PSA response after EBRT before brachytherapy predicts for long-term outcome; this may allow for risk stratification and intervention with higher LDR doses to improve outcomes. (C) 2010 Elsevier Inc.
Keyword:
Prostate cancer
Combined therapy
PSA
Response
Outcome
Prognosis
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
I
IF:
6.5
论文数:
4.8W
被引数:
4.2W
机构
引用论文
Amygdala protein kinase C epsilon regulates corticotropin‐releasing factor and anxiety‐like behavior
OAAI
.png){kind=icon}
OAAI分享收藏分享收藏Posttreatment prostate-specific antigen nadir highly predictive of distant failure and death from prostate cancer治疗后前列腺特异性抗原最低点高度预测前列腺癌远处衰竭和死亡
PREAI
分享收藏PSA response signatures - a powerful new prognostic indicator after radiation for prostate cancer?
PREAI
分享收藏
查看更多内容